Most organisations track productivity, performance and output. Very few measure the biological cost of producing that output. Yet the silent cost is substantial — and increasingly quantifiable.
Prajeeva’s Corporate & Executive Wellness programmes are designed to address all five dimensions — through measurable, biomarker-tracked, physician-led care delivered at the standard your leadership team deserves.
Discuss the Investment Case for Executive Health
Prajeeva offers corporates two structured programme types, designed for different populations within the organisation. Both can run independently or together, and both can be tailored to specific sector, demographic and clinical priorities.
Designed for C-suite executives, founders, board members and senior leadership. Premium per-executive pricing. The full Prajeeva clinical platform delivered as a structured 12-month executive health partnership.
Comprehensive baseline assessment — full longevity biomarker panel including ApoB, Lp(a), HOMA-IR, hs-CRP, homocysteine, Omega-3 Index, full hormonal panel, advanced lipid profiling and cognitive battery.
Biological age assessment — PhenoAge calculation included; epigenetic age (TruAge / GrimAge) available as a premium add-on.
VO2 Max, body composition (BIA) and grip strength baseline.
Sleep architecture assessment via wearable integration.
Personalised intervention protocol designed by the consulting physician.
Advanced therapeutic access — HBOT, IV NAD+, Ozone MAH, Neurofeedback, HRV Biofeedback, Whole-Body Cryotherapy, Infrared Sauna, Red Light Therapy & PEMF.
Quarterly biomarker monitoring with physician review.
Six-monthly cognitive battery reassessment.
Monthly 30-minute physician consultation (in-person or telehealth).
Designed for broader employee populations — typically 50 to 500 employees across senior management, mid-level professionals and specialised teams. Tiered investment structure based on organisation size and programme depth.
Annual comprehensive health assessment for every enrolled employee — longevity biomarker panel adapted to demographic risk profile.
Individual physician consultation following assessment — every employee receives personalised interpretation, not a generic report.
Risk stratification across the workforce — employees flagged for cardiovascular, metabolic, cognitive or mental health concerns are routed into appropriate intervention pathways.
Targeted intervention programmes for at-risk employees — 12 to 20 week structured pathways for those needing active clinical attention.
Workforce-wide education modules — sleep, cognitive performance, metabolic health, recovery.
Optional executive-tier upgrade pathway for senior employees identified as needing deeper clinical care.
Aggregate workforce health reporting to the employer (anonymised, population-level).
Corporate wellness programmes too often measure participation — how many employees attended a session, downloaded an app, joined a step challenge. Prajeeva measures biology. The metrics that matter are the metrics that connect directly to health and performance.
Aggregate biological age improvement across the cohort, tracked annually. The single most powerful indicator that a wellness programme is actually working at the cellular level.
ApoB, Lp(a), hs-CRP improvement across the leadership team. The most accurate predictors of cardiovascular events — the highest-cost preventable health crisis for any organisation.
HOMA-IR, HbA1c, fasting insulin, visceral adiposity. Insulin resistance is the precursor to type 2 diabetes, which now affects 11% of Indian adults and rises sharply in the 40–60 leadership demographic.
Validated cognitive battery measuring processing speed, working memory, sustained attention and executive function. Tracked against employee’s own baseline.
Time in deep and REM sleep, sleep onset latency, nighttime awakenings, HRV during sleep. Sleep quality is the single strongest predictor of executive decision quality.
VO2 Max measurement. The single strongest predictor of all-cause mortality — each MET increase associated with 10–25% mortality reduction (Mandsager et al, JAMA Network Open 2018).
At programme exit, the organisation receives an annual aggregate health report showing measurable, biomarker-tracked improvement across the enrolled population — with full individual confidentiality preserved. This is the data CHROs and CEOs need to evidence wellbeing investment and justify continuation.
Review a Sample Aggregate Report
Senior executives will not engage honestly with a corporate health programme if they fear their individual results may be visible to their employer. Prajeeva’s programme is built around explicit, contractual confidentiality protections that make engagement possible.
Individual health results, biomarker data, cognitive assessments and physician consultation content are confidential to the employee and the Prajeeva clinical team. They are never shared with the employer.
Employers receive only aggregate, anonymised population-level data — cohort biological age trajectory, cohort biomarker distributions, engagement metrics. Individual employees are never identifiable in employer reporting.
Cohort sizes for aggregate reporting are protected by minimum-N rules to prevent indirect identification. No employer report ever discloses results for a group small enough to risk de-anonymisation.
Specific medical conditions, mental health concerns or sensitive findings are never disclosed to the employer, even in aggregate, without the explicit written consent of the affected individual.
These protections are documented in the corporate engagement contract and the individual employee enrolment agreement.
An executive health programme that does not protect confidentiality is a surveillance programme. Prajeeva builds confidentiality into the architecture, not as an afterthought.
Review Our Confidentiality Framework
Different workforces carry different clinical risk profiles. A consulting firm’s senior leadership has different priorities from a hospital’s clinical staff, who in turn differ from a manufacturing CEO or a technology founder. Prajeeva’s programmes are configured around the specific risk patterns of the sector and demographic.
Prajeeva’s corporate engagements are designed to be clinically rigorous without being operationally burdensome for the employer. Three implementation models are available depending on workforce size, location and programme depth.
Initial Scoping Call With Hr / Leadership — Understanding Workforce Profile, Priorities, Budget, Timing.
Programme Design Proposal — Specific Package Recommendations, Investment Indication, Implementation Timeline.
Contracting — Corporate Engagement Agreement Including Confidentiality Framework, Deliverables, Reporting Cadence.
Launch — Employee Communication, Enrolment, Scheduling.
Delivery — Assessments, Consultations, Interventions Across The Agreed Timeline.
Reporting — Aggregate Workforce Health Report At Programme Milestones.
Continuation Review — Outcomes Review And Renewal Discussion.
Corporate wellness in India spans a wide price spectrum — from basic insurance-bundled offerings at a few thousand rupees per employee to premium executive health programmes costing several lakhs per executive. Prajeeva operates at the premium end of this spectrum, and the difference is substantive.
Basic 20–30 markers
Comprehensive longevity panel including ApoB, Lp(a), HOMA-IR, biological age
None or brief telephonic
Individual physician consultation for every participant
None
Validated cognitive battery
None
PhenoAge included; epigenetic age (TruAge / GrimAge) available
None
HBOT, IV NAD+, ozone MAH therapy (with mandatory G6PD screening), neurofeedback, HRV biofeedback, electric whole-body cryotherapy, infrared sauna, red light therapy and PEMF (pulsed electromagnetic field) therapy as clinically indicated
Self-reported engagement metrics
Biomarker-tracked, biological age trajectory, longitudinal cognitive data
Generic lifestyle advice
Individual physician-designed protocol
Frequently weak or unclear
Contractually documented, individual results never disclosed
Prajeeva is not the right partner for organisations seeking the lowest-cost wellness compliance solution. Prajeeva is the right partner for organisations whose leadership group is genuinely strategic to their performance and worth a substantive clinical investment to preserve.
Discuss Investment Sizing
Corporate engagements at Prajeeva begin with an initial scoping conversation — typically a 45 to 60 minute call with the HR / People leader and one or more senior stakeholders from the prospective employer. There is no commitment at this stage. The objective is to understand the organisation’s priorities, workforce profile, leadership health concerns and budget context, and to determine whether a Prajeeva engagement is the right fit.
Following the scoping call, Prajeeva prepares a formal programme proposal tailored to the organisation — including specific package recommendations, investment indication, implementation timeline and outcomes framework. Contracting typically follows within 4 to 6 weeks, with programme launch 2 to 4 weeks after contract signature.